BioSpace News Archive

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced it has been granted U.S. (Patent # 11,730,716) and European Patents covering local ocular delivery of the KIO-100 family of non-steroidal, anti-inflammatory small molecules.

This Pheo Para Awareness Week, The Carling Adrenal Center is working to bring attention to the prevalence of pheochromocytoma and paraganglioma, which are neuroendocrine tumors that make excess adrenaline.

Abivax SA announced the appointment of Patrick Malloy as new Senior Vice President Investor Relations.

Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences.

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:00 p.m. ET.

BD, a leading global medical technology company, announced that it will present at the following healthcare conferences.

Exelixis, Inc. announced it has appointed Amy Peterson, M.D., its next Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer.

Vaxxas announced that the global charitable foundation, Wellcome, has made an award totaling US$3.67 million to conduct IND-enabling studies and a first-in-human clinical study for a potentially second generation typhoid vaccine delivered by Vaxxas’ proprietary high-density microarray patch platform technology.

SK bioscience announced that the company has entered into a collaboration agreement with Vaxxas, an Australian biotechnology company developing a unique vaccine patch platform technology, to develop a second-generation typhoid conjugate vaccine with support from Wellcome.

Medtronic announced the outcome of the U.S. Food & Drug Administration Circulatory System Devices Panel meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation System.